Today on the AI Daily Brief, we're talking about the part of the economy that will thrive after AI.

The AI Daily Brief is a daily podcast and video about the most important news and discussions in AI.

All right, friends, quick notes before we dive in.

First of all, thank you to today's sponsors, KPMG, Granola, Super Intelligent, and Blitzy. To get an ad-free version of the show, go to patreon.com slash AI Daily Brief, or you can subscribe on Apple Podcasts. If you want to learn more about sponsoring the show, send us a note at sponsors at AIDilybrief.a. Now, two other quick notes. Yesterday, if you haven't seen yet the bonus operators episode, we launched our latest free AIDB training program. This one is a new FAR gas bar joint. She took a bunch of what I had built with Claw Camp and turned it into a more general, more extensible, adaptable, ongoing, agentic operating system program. So if you have dabbled with open claw or have wanted to, but want an agentic system that can slot in cloud code or codex or cursor or any other model or harness that you're using, check out AgentOS. There are links to it from aIDlydlybrief.aI. And when you sign up for AgentOS, you can actually do it with your new AIDB handle.

I plan on doing a lot of these free programs. And so instead of you having to sign up with emails and passwords every time, we've created now an AIDB single sign-on with, of course, cool vanity handles. So even if you aren't signing up for a program yet, but you just want to squat on your favorite three or four-digit handle, You can do that, once again, from AIDilybrief.A.I or directly at AIDBelabs.A.I. But with all of that out of the way,

let's talk about AI and the economy. Welcome back to the AI Daily Brief and happy weekend.

Listen, it will probably surprise none of you that I have what I would call major beef with the

AI jobs discussion.

It is not just that I think that the labs themselves are doing an unfathomably horrible job

pitching the value of AI.

I've made the comparison in the past to pharmaceutical commercials.

If you watch a 60-second pharma commercial on cable,

which is basically the only commercials they have at this point, the first 45 or 50 seconds are spent

around how this new drug or treatment is a miracle cure for some really painful, awful thing

that people have otherwise had to just live with. Now, yes, at the end, there are those 10 to 15

seconds of disclosures around potential side effects, some of which can be very, very bad.

But the emphasis is on the better life that you get to lead that justifies all of those risks.

In AI, we're basically exactly the reverse.

We spend the first 45 to 50 seconds of our metaphorical commercial, i.e. every time we get

a chance to talk to anyone about AI, talking about

how damn bad society is going to be after AI gets its hooks in, with only this tiny little

consideration of the potential benefits, which are presented as very hand-wavy at best.

...